Literature DB >> 35653357

Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.

Elliot Marseille, Jennifer M Mitchell, James G Kahn.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0263252.].

Entities:  

Year:  2022        PMID: 35653357      PMCID: PMC9162307          DOI: 10.1371/journal.pone.0269623

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  1 in total

1.  Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.

Authors:  Elliot Marseille; Jennifer M Mitchell; James G Kahn
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.